Feb 3, 2022Anavex Life Sciences to Announce Fiscal 2022 First Quarter Financial Results on Wednesday, 2/9/2022
Feb 1, 2022ANAVEX®2-73 (Blarcamesine) AVATAR Phase 3 Trial met Primary and Secondary Efficacy Endpoints
Nov 24, 2021Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Year End Financial Results
Nov 17, 2021Anavex Life Sciences to Announce Fiscal 2021 Year End Financial Results on Wed., November 24, 2021